The Surveillance & Research Subcommittee aims to establish an integrated AMR surveillance program across human health sectors in Oman. Key goals include standardizing AMR diagnostics and reporting, expanding surveillance to non-MOH sectors and the environment, improving data sharing and connectivity, and establishing benchmarks. The subcommittee will work with private and non-MOH sectors, identify focal points, provide trainings, and assess capacities. It also seeks to create a research platform bringing together all relevant stakeholders to identify priorities, opportunities, and policies to assess the AMR burden and distribute research projects. Progress will be monitored through activity and outcome indicators established in the operational plan.

1. Surveillance
& research
subcommittee

2. Goals and objectives
Surveillance:
1. 1. Integrated AMR surveillance program in human health to the national level including
MOH, non-MOH and private sectors:
 Standardizing AMR diagnostics and result reporting among the three sectors.
 Quality monitoring of AMR diagnostics (testing & reporting)
 Expand AMR surveillance to include environmental screening for for AMR and antimicrobial residues.
 Enhance laboratory capacities to detect and characterize MDRO.
 Improving AMR data sharing and connectivity
 Improving AMU data reporting and sharing
2. Filling gaps and expand the already established AMR surveillance in MOH sector

3. Research
1- Create a platform for
AMR research including
all human health
sectors, drug regulatory
agencies and academia
2-Enhance research
activities to better
understand the burden
at national level

4. Situational analysis
What is already in place:
National reference lab for AMR established
Standardization of antimicrobial testing done through workshops for
MOH and non-MOH laboratories
External Quality Assurance program (EQA) provided by the national
reference laboratories, CPHL to other MOH, non-MOH and 2 private
laboratories (Muscat private H & PDO)
Molecular AMR diagnostics in place at CPHL and is expanding
National surveillance system (OMASS) for AMR & AMU already in place
involving nine MOH sentinel sites.
Participating in Global AMR Surveillance System (GLASS) through sharing
data of AMR

5. Sr.No Objective Task Responsibility Timeframe
1. Integrated AMR
surveillance
program in
human health
three sectors
Identifying focal points to be involved as part of
working group from: private sector and non-MOH
sector.
Dr Amina Aljardani
Dr.Suleiman Al-Mawali
Dr.Azza Al-Rashdi
February 2024
2. Standardizing
AMR diagnostics
and result
reporting among
the three sectors.
Assessing AMR diagnostics, AMU
& data sharing in private sector:
Visit to private laboratories (Al-Shifa & Badr Al-
Samaa as nominated by Private sector)
*NMC is a potential candidate
The visit to include situation auditing for:
- Lab capacity & quality
- Data sharing and IT connectivity capacity
- AMU data reporting
Dr Amina Aljardani
Dr.Suleiman Al-Mawali
Dr.Adil Al-Wahaibi
Dr.Azza Al-Rashdi
Ms.Shabana Al-Belushi
February 2024
3. Standardizing
AMR diagnostics
and result
reporting among
the three sectors.
Provide training in antimicrobial susceptibility testing
to private sector (involving them in the next AST WS)
Dr.Azza Al-Rashdi
& AST WS group
To be decided
Usually done every 2 years,
last done May 2023.

6. Sr.No Objective Task Responsibility Timeframe
4. Improving AMR
data sharing
and
connectivity
Training on data sharing Dr.Adil Al-Wahibi
Dr.Sultan Al-Busaidi
5. Improving
AMU reporting
and data
sharing
Meetings/ training on AMU
reporting and data sharing
Sara Al-Belushi
Shabana Al-Belush

7. Sr.No Objective Task Responsibility Timeframe
6. Benchmarking for
AMR & AMU
- Establish bench marking for
MDROs.
- Establish benchmark for HAI
with MDROs
- Establish bench mark for AMU
All members of
subcommittee
April 2024
7. Quality
monitoring of
AMR diagnostics
(testing &
reporting)
Enrolling private sector in EQA
scheme of bacteriology provided
by CPHL (depending on the audit
result, if not enrolled in any other
EQA)
Dr.Azza Al-Rashdi September
2024

8. Sr.No Objective Task Responsibility Timeframe
8. Create a platform
for AMR research
- Include focal points from academia: SQU and
agriculture research centre to be part of
working group for research.
- All National AMR committee to participate
with research ideas according to their
subcommittee scope
- Prepare a list of priorities and gaps for AMR
research
- Assess the burden of AMR in humans including
the economic burden
- Put a clear policy on how these research
opportunities being distributed and monitored
(Msc students, PhD, technical staff,….etc) as
well as being approved.
All members of
subcommittee
Other subcommittee
members
All members of
subcommittee and working
group
All members of
subcommittee and working
group
April 2024
May 2024
June 2024
November 2024

9. Sr.No Objective Task Responsibility Timeframe
9. Funds opportunities Seek for fund opportunities for research and
training
All members of subcommittee Throughout the process
10.
11
Monitoring the
progress of
operational plan
Expand AMR
surveillance to include
environmental
screening for for AMR
and antimicrobial
residues
Through monitoring activities indicators and
later, through outcome indicators. These to be
discussed regularly during the meetings.
Establish the Whole Genome Sequencing
methods at CPHL as sustained program
All members of subcommittee
Amina Al-Jardani
Azza Al-Rashdi
Throughout the process

10. Activity
indicators
National policy for AMR
& AMU surveillance with
respect to data
collection, coordination
and resources across all
relevant sectors
developed.
Network of functional
surveillance sites with
regular exchange of
information set up for
both AMR and AMU
including MOH, non-
MOH and private sectors
of human health in
place.
Annual national AMR
surveillance report
published including all
relevant sectors.
Clear pathway for
detecting any emerging
AMR.

11. Outcome
indicators
ACHIEVING THE BENCHMARKS